_id
6918578c3c536f8df2317a53
Ticker
0JDK.LSE
Name
Iovance Biotherapeutics Inc.
Exchange
LSE
Address
825 Industrial Road, San Carlos, CA, United States, 94070
Country
UK
Sector
Industry
Currency
USD
Website
https://www.iovance.com
Description
Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic melanoma and metastatic renal cell carcinoma. It develops lifileucel for treatment of melanoma, cervical cancer, non-small cell lung cancer (NSCLC), endometrial cancer, and head and neck squamous cell carcinoma; IOV-2001 to treat chronic lymphocytic leukemia and small lymphocytic lymphoma; IOV-4001 for the treatment of melanoma and NSCLC; and IOV-3001, an antibody cytokine engrafted protein for use in the TIL therapy treatment regimen. The company has collaborations and licensing agreements with WuXi Advanced Therapies, Inc.; National Institutes of Health; the National Cancer Institute; H. Lee Moffitt Cancer Center; The University of Texas M.D. Anderson Cancer Center; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.
Last Close
2.77
Volume
2632
Current Price
2.73
Change
0.0789
Last Updated
2026-01-08T14:07:36.133Z
Image
https://logo.clearbit.com/www.iovance.com
Ipo Date
-
Market Cap
37305526400
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
67455000
Cost Of Revenue
1408000
Gross Profit
66047000
Operating Expenses
160948000
Operating Income
-94901000
Interest Expense
-
Pretax Income
-93658000
Net Income
-91253000
Eps
-0.2506695747959685
Dividends Per Share
-
Shares Outstanding
123170000
Income Tax Expense
-2405000
EBITDA
-84651000
Operating Margin
-140.68786598473056
Total Other Income Expense Net
1243000
Cash
158134000
Short Term Investments
142669000
Receivables
66760999
Inventories
51710000
Total Current Assets
429091000
Property Plant Equipment
175413000
Total Assets
904948000
Payables
31237000
Short Term Debt
7281000
Long Term Debt
-
Total Liabilities
202661000
Equity
702287000
Bs_currency_symbol
-
Depreciation
11708000
Change In Working Capital
-8533000
Cash From Operations
-78702000
Capital Expenditures
10844000
Cash From Investing
17012000
Cash From Financing
88056000
Net Change In Cash
25665000
Cf_currency_symbol
-
PE
-
PB
1.4151208978665417
ROE
-12.993690613666493
ROA
-10.083783819622786
FCF
-89546000
Fcf Percent
-1.3274924023423023
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
3.5
Growth Investing Score
2
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
67455000
Quarters > 0 > income Statement > cost Of Revenue
1408000
Quarters > 0 > income Statement > gross Profit
66047000
Quarters > 0 > income Statement > operating Expenses
160948000
Quarters > 0 > income Statement > operating Income
-94901000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-93658000
Quarters > 0 > income Statement > net Income
-91253000
Quarters > 0 > income Statement > eps
-0.2506695747959685
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
364037000
Quarters > 0 > income Statement > income Tax Expense
-2405000
Quarters > 0 > income Statement > EBITDA
-84651000
Quarters > 0 > income Statement > operating Margin
-140.68786598473056
Quarters > 0 > income Statement > total Other Income Expense Net
1243000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
158134000
Quarters > 0 > balance Sheet > short Term Investments
142669000
Quarters > 0 > balance Sheet > receivables
66760999
Quarters > 0 > balance Sheet > inventories
51710000
Quarters > 0 > balance Sheet > total Current Assets
429091000
Quarters > 0 > balance Sheet > property Plant Equipment
175413000
Quarters > 0 > balance Sheet > total Assets
904948000
Quarters > 0 > balance Sheet > payables
31237000
Quarters > 0 > balance Sheet > short Term Debt
7281000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
202661000
Quarters > 0 > balance Sheet > equity
702287000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-91253000
Quarters > 0 > cash Flow > depreciation
11708000
Quarters > 0 > cash Flow > change In Working Capital
-8533000
Quarters > 0 > cash Flow > cash From Operations
-78702000
Quarters > 0 > cash Flow > capital Expenditures
10844000
Quarters > 0 > cash Flow > cash From Investing
17012000
Quarters > 0 > cash Flow > cash From Financing
88056000
Quarters > 0 > cash Flow > net Change In Cash
25665000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.2506695747959685
Quarters > 0 > ratios > PB
1.4151208978665417
Quarters > 0 > ratios > ROE
-12.993690613666493
Quarters > 0 > ratios > ROA
-10.083783819622786
Quarters > 0 > ratios > FCF
-89546000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-1.3274924023423023
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
59952000
Quarters > 1 > income Statement > cost Of Revenue
62904000
Quarters > 1 > income Statement > gross Profit
-2952000
Quarters > 1 > income Statement > operating Expenses
110822000
Quarters > 1 > income Statement > operating Income
-113774000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-109670000
Quarters > 1 > income Statement > net Income
-111658000
Quarters > 1 > income Statement > eps
-0.3337947033131945
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
334511000
Quarters > 1 > income Statement > income Tax Expense
1988000
Quarters > 1 > income Statement > EBITDA
-97732000
Quarters > 1 > income Statement > operating Margin
-189.77515345609822
Quarters > 1 > income Statement > total Other Income Expense Net
4104000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
132469000
Quarters > 1 > balance Sheet > short Term Investments
168714000
Quarters > 1 > balance Sheet > receivables
59938000
Quarters > 1 > balance Sheet > inventories
49833000
Quarters > 1 > balance Sheet > total Current Assets
422500000
Quarters > 1 > balance Sheet > property Plant Equipment
172422000
Quarters > 1 > balance Sheet > total Assets
907437000
Quarters > 1 > balance Sheet > payables
32003999
Quarters > 1 > balance Sheet > short Term Debt
8070000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
208949000
Quarters > 1 > balance Sheet > equity
698488000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-111658000
Quarters > 1 > cash Flow > depreciation
11938000
Quarters > 1 > cash Flow > change In Working Capital
9190000
Quarters > 1 > cash Flow > cash From Operations
-67447000
Quarters > 1 > cash Flow > capital Expenditures
7461000
Quarters > 1 > cash Flow > cash From Investing
13842000
Quarters > 1 > cash Flow > cash From Financing
13230000
Quarters > 1 > cash Flow > net Change In Cash
-39758000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.3337947033131945
Quarters > 1 > ratios > PB
1.3074169205483845
Quarters > 1 > ratios > ROE
-15.985671908465141
Quarters > 1 > ratios > ROA
-12.304766060894586
Quarters > 1 > ratios > FCF
-74908000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.2494662396583933
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
49324000
Quarters > 2 > income Statement > cost Of Revenue
49741000
Quarters > 2 > income Statement > gross Profit
-417000
Quarters > 2 > income Statement > operating Expenses
120804000
Quarters > 2 > income Statement > operating Income
-121221000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-118001000
Quarters > 2 > income Statement > net Income
-116163000
Quarters > 2 > income Statement > eps
-0.35978480369686683
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
322868000
Quarters > 2 > income Statement > income Tax Expense
-1838000
Quarters > 2 > income Statement > EBITDA
-113026000
Quarters > 2 > income Statement > operating Margin
-245.76473927499796
Quarters > 2 > income Statement > total Other Income Expense Net
3220000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
171668000
Quarters > 2 > balance Sheet > short Term Investments
188045000
Quarters > 2 > balance Sheet > receivables
70938000
Quarters > 2 > balance Sheet > inventories
65545000
Quarters > 2 > balance Sheet > total Current Assets
512649000
Quarters > 2 > balance Sheet > property Plant Equipment
162487000
Quarters > 2 > balance Sheet > total Assets
966740000
Quarters > 2 > balance Sheet > payables
28489000
Quarters > 2 > balance Sheet > short Term Debt
9499000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
198875000
Quarters > 2 > balance Sheet > equity
767865000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-116163000
Quarters > 2 > cash Flow > depreciation
11065000
Quarters > 2 > cash Flow > change In Working Capital
-19682000
Quarters > 2 > cash Flow > cash From Operations
-103694000
Quarters > 2 > cash Flow > capital Expenditures
6211000
Quarters > 2 > cash Flow > cash From Investing
15867000
Quarters > 2 > cash Flow > cash From Financing
143315000
Quarters > 2 > cash Flow > net Change In Cash
55996000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.35978480369686683
Quarters > 2 > ratios > PB
1.1478966224531655
Quarters > 2 > ratios > ROE
-15.128049852513136
Quarters > 2 > ratios > ROA
-12.01595051409893
Quarters > 2 > ratios > FCF
-109905000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-2.228225610250588
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
73694000
Quarters > 3 > income Statement > cost Of Revenue
51684000
Quarters > 3 > income Statement > gross Profit
22010000
Quarters > 3 > income Statement > operating Expenses
108586000
Quarters > 3 > income Statement > operating Income
-86576000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-77001000
Quarters > 3 > income Statement > net Income
-78559000
Quarters > 3 > income Statement > eps
-0.2576634195939519
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
304890000
Quarters > 3 > income Statement > income Tax Expense
1558000
Quarters > 3 > income Statement > EBITDA
-65314000
Quarters > 3 > income Statement > operating Margin
-117.48039189079165
Quarters > 3 > income Statement > total Other Income Expense Net
9575000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
115694000
Quarters > 3 > balance Sheet > short Term Investments
208087000
Quarters > 3 > balance Sheet > receivables
69340000
Quarters > 3 > balance Sheet > inventories
51520000
Quarters > 3 > balance Sheet > total Current Assets
457018000
Quarters > 3 > balance Sheet > property Plant Equipment
164282000
Quarters > 3 > balance Sheet > total Assets
910426000
Quarters > 3 > balance Sheet > payables
27509000
Quarters > 3 > balance Sheet > short Term Debt
12896000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
200021000
Quarters > 3 > balance Sheet > equity
710405000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-78559000
Quarters > 3 > cash Flow > depreciation
11687000
Quarters > 3 > cash Flow > change In Working Capital
-37979000
Quarters > 3 > cash Flow > cash From Operations
-73296000
Quarters > 3 > cash Flow > capital Expenditures
4168000
Quarters > 3 > cash Flow > cash From Investing
23677000
Quarters > 3 > cash Flow > cash From Financing
2309000
Quarters > 3 > cash Flow > net Change In Cash
-48492000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.2576634195939519
Quarters > 3 > ratios > PB
1.1716551826071044
Quarters > 3 > ratios > ROE
-11.058339961008157
Quarters > 3 > ratios > ROA
-8.628817718298906
Quarters > 3 > ratios > FCF
-77464000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.0511574890764512
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
164070000
Annuals > 0 > income Statement > cost Of Revenue
146399000
Annuals > 0 > income Statement > gross Profit
17671000
Annuals > 0 > income Statement > operating Expenses
412949000
Annuals > 0 > income Statement > operating Income
-395278000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-375005000
Annuals > 0 > income Statement > net Income
-372177000
Annuals > 0 > income Statement > eps
-1.283913521942065
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
289877000
Annuals > 0 > income Statement > income Tax Expense
-2828000
Annuals > 0 > income Statement > EBITDA
-331399000
Annuals > 0 > income Statement > operating Margin
-240.92033887974645
Annuals > 0 > income Statement > total Other Income Expense Net
20273000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
115694000
Annuals > 0 > balance Sheet > short Term Investments
208087000
Annuals > 0 > balance Sheet > receivables
69340000
Annuals > 0 > balance Sheet > inventories
51520000
Annuals > 0 > balance Sheet > total Current Assets
457018000
Annuals > 0 > balance Sheet > property Plant Equipment
164282000
Annuals > 0 > balance Sheet > total Assets
910426000
Annuals > 0 > balance Sheet > payables
27509000
Annuals > 0 > balance Sheet > short Term Debt
25792000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
200021000
Annuals > 0 > balance Sheet > equity
710405000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-372177000
Annuals > 0 > cash Flow > depreciation
43606000
Annuals > 0 > cash Flow > change In Working Capital
-122556000
Annuals > 0 > cash Flow > cash From Operations
-352977000
Annuals > 0 > cash Flow > capital Expenditures
11069000
Annuals > 0 > cash Flow > cash From Investing
-96411000
Annuals > 0 > cash Flow > cash From Financing
390664000
Annuals > 0 > cash Flow > net Change In Cash
806000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-1.283913521942065
Annuals > 0 > ratios > PB
1.1139620498166538
Annuals > 0 > ratios > ROE
-52.38941167362279
Annuals > 0 > ratios > ROA
-40.8794344625483
Annuals > 0 > ratios > FCF
-364046000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-2.2188456146766624
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1189000
Annuals > 1 > income Statement > cost Of Revenue
10755000
Annuals > 1 > income Statement > gross Profit
-9566000
Annuals > 1 > income Statement > operating Expenses
450993000
Annuals > 1 > income Statement > operating Income
-460559000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-447516000
Annuals > 1 > income Statement > net Income
-444037000
Annuals > 1 > income Statement > eps
-1.8884664293521485
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
235131000
Annuals > 1 > income Statement > income Tax Expense
-3479000
Annuals > 1 > income Statement > EBITDA
-449013000
Annuals > 1 > income Statement > operating Margin
-38734.9873843566
Annuals > 1 > income Statement > total Other Income Expense Net
13043000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
114888000
Annuals > 1 > balance Sheet > short Term Investments
164979000
Annuals > 1 > balance Sheet > receivables
151000
Annuals > 1 > balance Sheet > inventories
10372000
Annuals > 1 > balance Sheet > total Current Assets
307848000
Annuals > 1 > balance Sheet > property Plant Equipment
176545000
Annuals > 1 > balance Sheet > total Assets
780351000
Annuals > 1 > balance Sheet > payables
33123000
Annuals > 1 > balance Sheet > short Term Debt
15554000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
195738000
Annuals > 1 > balance Sheet > equity
584613000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-444037000
Annuals > 1 > cash Flow > depreciation
33127000
Annuals > 1 > cash Flow > change In Working Capital
-11349000
Annuals > 1 > cash Flow > cash From Operations
-361820000
Annuals > 1 > cash Flow > capital Expenditures
22290000
Annuals > 1 > cash Flow > cash From Investing
-155242000
Annuals > 1 > cash Flow > cash From Financing
462959000
Annuals > 1 > cash Flow > net Change In Cash
-56843000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.8884664293521485
Annuals > 1 > ratios > PB
1.098004372123097
Annuals > 1 > ratios > ROE
-75.95400718081876
Annuals > 1 > ratios > ROA
-56.90221451628818
Annuals > 1 > ratios > FCF
-384110000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-323.0529857022708
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
-
Annuals > 2 > income Statement > cost Of Revenue
21135000
Annuals > 2 > income Statement > gross Profit
-21135000
Annuals > 2 > income Statement > operating Expenses
377743000
Annuals > 2 > income Statement > operating Income
-398878000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-395893000
Annuals > 2 > income Statement > net Income
-395893000
Annuals > 2 > income Statement > eps
-2.485843814164349
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
159259000
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-374758000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
2985000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
231731000
Annuals > 2 > balance Sheet > short Term Investments
240114000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
479116000
Annuals > 2 > balance Sheet > property Plant Equipment
178247000
Annuals > 2 > balance Sheet > total Assets
663982000
Annuals > 2 > balance Sheet > payables
26603000
Annuals > 2 > balance Sheet > short Term Debt
25174000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
164344000
Annuals > 2 > balance Sheet > equity
499638000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-395893000
Annuals > 2 > cash Flow > depreciation
21135000
Annuals > 2 > cash Flow > change In Working Capital
-2892000
Annuals > 2 > cash Flow > cash From Operations
-292757000
Annuals > 2 > cash Flow > capital Expenditures
20425000
Annuals > 2 > cash Flow > cash From Investing
256455000
Annuals > 2 > cash Flow > cash From Financing
190150000
Annuals > 2 > cash Flow > net Change In Cash
153502000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-2.485843814164349
Annuals > 2 > ratios > PB
0.8701841533270087
Annuals > 2 > ratios > ROE
-79.23596683999216
Annuals > 2 > ratios > ROA
-59.62405607380923
Annuals > 2 > ratios > FCF
-313182000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
41
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
13980000
Annuals > 3 > income Statement > gross Profit
-13980000
Annuals > 3 > income Statement > operating Expenses
328723000
Annuals > 3 > income Statement > operating Income
-342703000
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-342252000
Annuals > 3 > income Statement > net Income
-342252000
Annuals > 3 > income Statement > eps
-2.2310209509406413
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
153406000
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-328272000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
451000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
78229000
Annuals > 3 > balance Sheet > short Term Investments
426181000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
507956000
Annuals > 3 > balance Sheet > property Plant Equipment
169921000
Annuals > 3 > balance Sheet > total Assets
777333000
Annuals > 3 > balance Sheet > payables
27377000
Annuals > 3 > balance Sheet > short Term Debt
10114000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
155674000
Annuals > 3 > balance Sheet > equity
621659000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-342252000
Annuals > 3 > cash Flow > depreciation
13980000
Annuals > 3 > cash Flow > change In Working Capital
24553000
Annuals > 3 > cash Flow > cash From Operations
-227941000
Annuals > 3 > cash Flow > capital Expenditures
37574000
Annuals > 3 > cash Flow > cash From Investing
132000
Annuals > 3 > cash Flow > cash From Financing
239268000
Annuals > 3 > cash Flow > net Change In Cash
10900000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-2.2310209509406413
Annuals > 3 > ratios > PB
0.673678624454886
Annuals > 3 > ratios > ROE
-55.054619976546626
Annuals > 3 > ratios > ROA
-44.02900687350209
Annuals > 3 > ratios > FCF
-265515000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
41
Valuation > metrics > PE
-0.2506695747959685
Valuation > metrics > PB
1.4151208978665417
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-12.993690613666493
Profitability > metrics > ROA
-21.266584477418544
Profitability > metrics > Net Margin
-1.3527981617374547
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.2885729053791399
Risk > metrics > Interest Coverage
-10.536360608415677
Risk > final Score
18
Risk > verdict
High
Liquidity > metrics > Current Ratio
11.140012461706215
Liquidity > metrics > Quick Ratio
9.797523235889713
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
22
Prev Risks > 1
-37
Prev Risks > 2
30
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:54:29.860Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-0.17
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.2507
Earnings History > 1 > eps Estimate
-0.26
Earnings History > 1 > eps Difference
0.0093
Earnings History > 1 > surprise Percent
3.5769
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.3338
Earnings History > 2 > eps Estimate
-0.28
Earnings History > 2 > eps Difference
-0.0538
Earnings History > 2 > surprise Percent
-19.2143
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-07
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.3598
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-26
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.2577
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-07
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.2755
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-08
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.3409
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-09
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.4244
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-26
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.4547
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-07
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.4628
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-08
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.4746
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-09
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.5024
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-28
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.6392
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-03
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.6312
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-04
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-0.6317
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-05
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-0.5831
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-24
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-0.633
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-04
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-0.5538
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-05
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-0.5291
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-06
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-0.512
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2020-12-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-0.4661
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-09-30
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
-0.3998
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-0.4732
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-0.5499
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2019-12-31
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
-0.5034
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-09-30
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
-0.399
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-06-30
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
-0.3848
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-03-31
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
-0.2994
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2018-12-31
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
-0.2735
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-09-30
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
-0.3558
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-06-30
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
-
Earnings History > 30 > eps Actual
-0.3398
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-03-31
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
-
Earnings History > 31 > eps Actual
-0.3143
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic melanoma and metastatic renal cell carcinoma. It develops lifileucel for treatment of melanoma, cervical cancer, non-small cell lung cancer (NSCLC), endometrial cancer, and head and neck squamous cell carcinoma; IOV-2001 to treat chronic lymphocytic leukemia and small lymphocytic lymphoma; IOV-4001 for the treatment of melanoma and NSCLC; and IOV-3001, an antibody cytokine engrafted protein for use in the TIL therapy treatment regimen. The company has collaborations and licensing agreements with WuXi Advanced Therapies, Inc.; National Institutes of Health; the National Cancer Institute; H. Lee Moffitt Cancer Center; The University of Texas M.D. Anderson Cancer Center; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Iovance Biotherapeutics Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.17
Date
2025-09-30
EPS Actual
-0.2507
EPS Estimate
-0.26
EPS Difference
0.0093
Surprise Percent
3.5769%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.